Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2003-04-22
2008-12-02
Desai, Anand U (Department: 1656)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S300000
Reexamination Certificate
active
07459424
ABSTRACT:
Peptide sequences derived from the V5 domain of isozymes of protein kinase C for use in pain management are described. Also described are compositions comprising the peptides for treating pain and/or inducing analgesia. Methods of pain treatment and methods of identifying compounds that mimic the activity of the peptides are also described.
REFERENCES:
patent: 4351829 (1982-09-01), Zetler et al.
patent: 5776685 (1998-07-01), Riedel
patent: 5783405 (1998-07-01), Mochly-Rosen et al.
patent: 5935803 (1999-08-01), Vasquez et al.
patent: 6165977 (2000-12-01), Mochly-Rosen
patent: 6376467 (2002-04-01), Messing et al.
patent: 6395306 (2002-05-01), Cui et al.
patent: 2003/0223981 (2003-12-01), Mochly-Rosen
patent: 2004/0009922 (2004-01-01), Mochly-Rosen
patent: 2005/0215483 (2005-09-01), Mochly-Rosen
patent: WO 94/04686 (1994-03-01), None
patent: WO 97/14038 (1997-04-01), None
patent: WO 99/43805 (1999-09-01), None
patent: WO 00/01415 (2000-01-01), None
patent: WO 00/53218 (2000-09-01), None
patent: WO 01/46252 (2001-06-01), None
patent: WO 01/75067 (2001-11-01), None
Knopf, J. et al. Cell 46:491-502 (1986).
Chen, L. et al. Chemistry & Biology 8: 1123-1129 (2001).
Malmberg, A. et al. Science 278: 279-283 (1997).
Jones et al., Cell Regulation 2: 1001-1009 (1991), “Molecular cloning of a second form of rac protein kinase”.
Meier et al., Journal of Biological Chemistry 272(48): 30491-30497 (1997), “Mitogenic activation, phosphorylation, and nuclear translocation of protein kinase B beta”.
Csukai et al., “Pharmacologic modulation of protein kinase C isozymes: the role of racks and subcellular localisation”, Pharmacological Research 39(4): 253-259 (1999).
Mochly-Rosen et al., “Anchoring proteins for protein kinase C: a means for isozyme selectivity”, FASEB Journal 12: 35-42 (1998).
Julius, D. and Basbaum, A.I.,Nature, 413:203-210, (2001).
Igwe, O.J. and Chronwall, B.M.,Neuroscience 104(3):875-890, (2001).
Martin, W.J., et al.,Neuroscience 88(4):1267-1274, (1999).
Martin, W.J., et al.,The Journal of Neuroscience 21(14):5321-5327, (2001).
Petersen-Zeitz, K.R. and Basbaum, A.I.,Pain Supplement 6:S5-S12, (1999).
Wen, Z.H., et al.,Neuroscience Letters 309:25-28, (2001).
Stebbins, E.G. and Mochly-Rosen, D.,The Journal of Biological Chemistry,276(32):29644-29650, (2001).
Chen, L., et al.,PNAS, 98(20):11114-11119, (2001).
Falnes, P.O., et al.,Biochemistry 40:4349-4358, (2001).
Aley et al.,The Journal of Neurosceince,20(12):4680-4685 (2000).
Dina et al.,The Journal of Neurosceince,20(22):8614-8619 (2000).
Ono et al.,Science,236:1116-1120 (1987).
Kubo et al.,FEBS Letters,223(1):138-142 (1987).
Gokmen-Polar et al., “Mapping of a Molecular determinant for Protien Kinase C Betall Isozyme Function”,The Journal of Biological Chemistry,273(32):20261-20266 (1998).
Sweitzer et al., “Developmental Regulation of Inflammatory Pain by Protein Kinase C”, Society for Neuroscience Abstract Viewer and Itinerary Planner, 32ndAnnual Meeting of the Society of Neuroscience (2002).
Kendig Joan J.
Mochly-Rosen Daria
Sweitzer Sarah M.
Yeomans David C.
Desai Anand U
King & Spalding LLP
Mohr Judy M.
The Borad of Trustees of the Leland Stanford Junior University
LandOfFree
Peptide inhibitors of protein kinase C γ for pain... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide inhibitors of protein kinase C γ for pain..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide inhibitors of protein kinase C γ for pain... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4029431